In obese or morbidly obese adults with NVAF, apixaban was associated with lower systemic embolization, myocardial infarction, gastrointestinal hemorrhage, and major bleeding than rivaroxaban, with no significant differences in ischemic stroke, intracranial bleeding, hemorrhagic stroke, or mortality.
M. Iqbal, M. Khan, Fazeel Ahmed et al.· Circulation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.